Efficacy, Safety and Immunogenicity of BI 695501 Versus Humira® in Patients With Moderate to Severe Chronic Plaque Psoriasis
Clinical trial NCT02850965 · COMPLETED
Trial details
- NCT number
- NCT02850965
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-17
- Primary completion
- 2018-01-17
- Enrollment
- 318
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.